These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005]. Yang QW, Xu YC, Chen MJ, Hu YJ, Ni YX, Sun JY, Yu YS, Kong HS, He L, Wu WY, Ye HF, Yang YM, Zhu LN, Guo SH, Ji P, Zhu ZH, Ren JK, Zhang LX, Sun ZY, Zhu XH, Tong MQ, Zhao WS, Mei YN, Liu Y, Zhang ZJ, Duan Q, Li D, Liu PP, Wang J, Han LX, Wang H, Xie XL. Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2753-8. PubMed ID: 18167265 [Abstract] [Full Text] [Related]
24. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance. Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M. Int J Infect Dis; 2008 May 23; 12(3):256-64. PubMed ID: 17981482 [Abstract] [Full Text] [Related]
27. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. Schmitz FJ, Fluit AC, Gondolf M, Beyrau R, Lindenlauf E, Verhoef J, Heinz HP, Jones ME. J Antimicrob Chemother; 1999 Feb 23; 43(2):253-9. PubMed ID: 11252331 [Abstract] [Full Text] [Related]
28. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)]. Jotzoff M. Med Klin; 1978 Jun 16; 73(24):914-7. PubMed ID: 661734 [Abstract] [Full Text] [Related]
30. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia. Jones RN, Li Q, Kohut B, Biedenbach DJ, Bell J, Turnidge JD. Diagn Microbiol Infect Dis; 2006 Jan 16; 54(1):63-71. PubMed ID: 16368476 [Abstract] [Full Text] [Related]
32. In vitro antimicrobial activity of diethyldithiocarbamate and dimethyldithiocarbamate against methicillin-resistant Staphylococcus. Taylor EH, Walker EM, Bartelt M, Day S, Pappas AA. Ann Clin Lab Sci; 1987 Jan 16; 17(3):171-7. PubMed ID: 3037985 [Abstract] [Full Text] [Related]
36. [Mechanisms of resistance to dactimicin and isepamicin in clinical strains of gram-negative rods isolated in Czechoslovakia]. Kettner M, Miller GH, Inouye S. Bratisl Lek Listy; 1992 Mar 16; 93(3):131-5. PubMed ID: 1525686 [Abstract] [Full Text] [Related]
37. In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme. Li CR, Yang XY, Lou RH, Zhang WX, Wang YM, Yuan M, Li Y, Chen HZ, Hong B, Sun CH, Zhao LX, Li ZR, Jiang JD, You XF. Antimicrob Agents Chemother; 2008 Nov 16; 52(11):3875-82. PubMed ID: 18710917 [Abstract] [Full Text] [Related]
38. Antimicrobial susceptibility of non-fermenting Gram-negative isolates to isepamicin in a region with high antibiotic resistance. Samonis G, Maraki S, Vouloumanou EK, Georgantzi GG, Kofteridis DP, Falagas ME. Eur J Clin Microbiol Infect Dis; 2012 Nov 16; 31(11):3191-8. PubMed ID: 22752194 [Abstract] [Full Text] [Related]
39. In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan. Shen GH, Wu BD, Wu KM, Chen JH. Antimicrob Agents Chemother; 2007 May 16; 51(5):1849-51. PubMed ID: 17353252 [Abstract] [Full Text] [Related]